ImmunologybioRxivPreprint
Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus
Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari…·Chairul Anwar Nidom
This study evaluates the immunogenicity, efficacy, and safety of a recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in various animal models, showing significant antibody responses and protection against infection.
DOI 10.1101/2024.12.18.629000